Deep learning for detecting and early predicting chronic obstructive pulmonary disease from spirogram time series
Open Access
- 15 February 2025
- journal article
- research article
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 11 (1) , 1-16
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung condition characterized by airflow obstruction. Current diagnostic methods primarily rely on identifying prominent features in spirometry (Volume-Flow time series) to detect COPD, but they are not adept at predicting future COPD risk based on subtle data patterns. In this study, we introduce a novel deep learning-based approach, DeepSpiro, aimed at the early prediction of future COPD risk. DeepSpiro consists of four key components: SpiroSmoother for stabilizing the Volume-Flow curve, SpiroEncoder for capturing volume variability-pattern through key patches of varying lengths, SpiroExplainer for integrating heterogeneous data and explaining predictions through volume attention, and SpiroPredictor for predicting the disease risk of undiagnosed high-risk patients based on key patch concavity, with prediction horizons of 1–5 years, or even longer. Evaluated on the UK Biobank dataset, DeepSpiro achieved an AUC of 0.8328 for COPD detection and demonstrated strong predictive performance for future COPD risk (p-value < 0.001). In summary, DeepSpiro can effectively predict the long-term progression of COPD disease.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impactRespirology, 2021
- From GOLD 0 to Pre-COPDAmerican Journal of Respiratory and Critical Care Medicine, 2021
- Advances in Chronic Obstructive Pulmonary DiseaseAnnual Review of Medicine, 2021
- Determining crucial genes associated with COVID-19 based on COPD Findings✶,✶✶Computers in Biology and Medicine, 2021
- The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population studyClinical Physiology and Functional Imaging, 2020
- Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and MortalityJAMA, 2019
- COPD Guidelines: A Review of the 2018 GOLD ReportMayo Clinic Proceedings, 2018
- Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: An evidence-based reviewRespiratory Medicine, 2011
- Lung function testing in the elderly—Can we still use FEV1/FVC<70% as a criterion of COPD?Respiratory Medicine, 2007
- Long Short-Term MemoryNeural Computation, 1997